X
Edition:
United Kingdom

  • Business
    • Business Home
    • Deals
    • Aerospace & Defence
    • Autos
    • Banks
    • Central Banks
    • Reuters Summits
    • Business Video
  • Markets
    • Markets Home
    • UK Markets
    • European Markets
    • Market Analysis
    • Global Market Data
    • Indices
    • Stocks
    • Earnings
    • FXpert
    • Currencies
    • Commodities
    • Funds
  • World
    • World Home
    • Special Reports
    • Reuters Investigates
    • Euro Zone
    • Germany
    • France
    • U.S.
    • China
    • Middle East
    • Africa
    • Russia
    • India
    • Japan
    • World Video
  • UK
    • UK Home
    • Politics
    • Economy
  • Tech
    • Technology Home
    • Media
    • Science
    • Tech Video
    • Innovation
  • Money
    • Money Home
    • Analyst Research
    • Stock Screener
    • Fund Screener
  • Commentary
    • Commentary Home
  • Breakingviews
    • Breakingviews Home
  • Sport
    • Sport Home
    • Football
    • Formula One
    • Tennis
    • Cricket
    • Golf
    • Rugby Union
    • Sport Video
  • Life
    • Lifestyle Home
    • Health
    • Environment
    • Entertainment
    • Arts
    • Oddly Enough
    • Lifestyle Video
    • Entertainment Video
    • Environment Video
  • Pictures
    • Pictures Home
    • The Wider Image
    • Photographers
    • Focus 360
  • Video
Exercise "as good as medicines" in treating heart disease
  • Africa
    América Latina
  • عربي
    Argentina
  • Brasil
    Canada
  • 中国
    Deutschland
  • España
    France
  • India
    Italia
  • 日本
    México
  • РОССИЯ
    United Kingdom
  • United States
Healthcare | Wed Oct 2, 2013 | 12:55pm BST

Exercise "as good as medicines" in treating heart disease

* Evidence review finds "blind spot" on benefits of exercise

* Cardiovascular disease is the world's biggest killer

* Researchers say new drugs should be compared with exercise

By Kate Kelland

LONDON, Oct 2 Exercise may be just as good as medication to treat heart disease and should be included as a comparison when new drugs are being developed and tested, scientists said on Wednesday.

In a large review published in the British Medical Journal, researchers from Britain's London School of Economics and Harvard and Stanford universities in the United States found no statistically detectable differences between exercise and drugs for patients with coronary heart disease or prediabetes, when a person shows symptoms that may develop into full-blown diabetes.

For patients recovering from stroke, the review - which analysed the results of 305 studies covering almost 340,000 participants - found that exercise was more effective than drug treatment.

Cardiovascular disease is the world's number one killer, leading to at least 17 million deaths a year.

"In cases where drug options provide only modest benefit, patients deserve to understand the relative impact that physical activity might have on their condition," the researchers wrote.

The review also said the amount of trial evidence on the health benefits of exercise is considerably smaller than that on drugs, which the scientists said may have had an impact on their results.

They argued that this "blind spot" over exercise in scientific evidence "prevents prescribers and their patients from understanding the clinical circumstances where drugs might provide only modest improvement but exercise could yield more profound or sustainable gains".

The review adds to a large body of evidence showing that regular exercise is key to human health.

According to the Geneva-based World Health Organization (WHO), physical inactivity is the fourth leading risk factor for global mortality, causing an estimated 3.2 million deaths around the world each year.

The WHO says regular moderate intensity physical activity - such as walking, cycling or participating in sports - can reduce the risk of cardiovascular diseases, diabetes, colon and breast cancer, and depression, as well as cutting the risk of bone fractures and helping to control body weight.

In the United States, where health experts estimate half of adults will be obese by 2030 unless lifestyle habits change, the Centers for Disease Control and Prevention says less than 48 percent of adults exercise enough to improve their health. (Editing by Elizabeth Piper)

Next In Healthcare

BRIEF-Alfataliglicerase approved for pediatric indications in Brazil for the treatment of gaucher disease in children four years and older

* Alfataliglicerase approved for pediatric indications in brazil for the treatment of gaucher disease in children four years and older

BRIEF-Amedica reports new sales leadership and provides regulatory updates

* FDA also notified company that new pedicle screw system, taurus, has been cleared for commercialization

BRIEF-Gilead Capital Lp reports 5 percent stake in Landauer

* Gilead Capital Lp reports 5 percent stake in Landauer Inc as of Nov. 21 - sec filing Source text - http://bit.ly/2fYUJ91 Further company coverage:

MORE FROM REUTERS

Sponsored Content

From Around the Web Promoted by Taboola

Trending Stories

    Sponsored Topics

    X
    Follow Reuters:
    • Follow Us On Twitter
    • Follow Us On Facebook
    • RSS
    • Follow Us On LinkedIn
    Subscribe: Newsletters | Apps
    Reuters News Agency | Brand Attribution Guidelines

    Reuters is the news and media division of Thomson Reuters. Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Learn more about Thomson Reuters products:

    Eikon
    Information, analytics and exclusive news on financial markets - delivered in an intuitive desktop and mobile interface
    Elektron
    Everything you need to empower your workflow and enhance your enterprise data management
    World-Check
    Screen for heightened risk individual and entities globally to help uncover hidden risks in business relationships and human networks
    Westlaw
    Build the strongest argument relying on authoritative content, attorney-editor expertise, and industry defining technology
    ONESOURCE
    The most comprehensive solution to manage all your complex and ever-expanding tax and compliance needs
    CHECKPOINT
    The industry leader for online information for tax, accounting and finance professionals

    All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.

    • Site Feedback
    • Corrections
    • Advertise With Us
    • Advertising Guidelines
    • AdChoices
    • Terms of Use
    • Privacy Policy